Výsledky vyhľadávania - "молекулярная генетика"

Zdroj: Medical science of Uzbekistan; No. 2 (2025): March-April; 74-79 ; Медицинская наука Узбекистана; № 2 (2025): Март-Апрель; 74-79 ; O`zbekiston tibbiyot ilmi; No. 2 (2025): Mart-Aprel; 74-79 ; 2181-3612

Predmety: Pro72Arg polymorphism of the TP53 gene, rs1042522, MPN, molecular genetics, gene mutations and cancer, prognosis of myeloproliferative disorders, полиморфизм Pro72Arg гена TP53, МПН, молекулярная генетика, генные мутации и рак, прогнозирование миелопролиферативных расстройств, TP53 genining Pro72Arg polimorfizmi, molekulyar genetika, gen mutatsiyalari va saraton, mieloproliferativ kasalliklar prognozi

Popis súboru: application/pdf

Relation: https://fdoctors.uz/index.php/journal/article/view/122/91; https://fdoctors.uz/index.php/journal/article/view/122

Dostupnosť: https://fdoctors.uz/index.php/journal/article/view/122
https://doi.org/10.56121/2181-3612-2025-2-74-79

View record from BASE

Nájsť tento článok vo Web of Science

5

Study results on the molecular genetic, morphometric and sexual characteristics of the beluga (Huso huso L., 1758) grown in the aquaculture of the Republic of Belarus

Autori: A.Y. Barmintseva N.V. Barulin N.A. Balashenko a ďalší

Zdroj: Azerbaijan Journal of Physiology. 37:69-80

Predmety: молекулярная генетика, akvakultura, morphometric characteristics, морфометрические характеристики, sex determination, adi bölgə (Huso huso L, определение пола, morfometrik xüsusiyyətlər, 1758), белуга (Huso Huso L, cinsiyyətin təyini, molekulyar genetika, aquaculture, molecular genetics, Beluga (Huso huso L, 14. Life underwater, аквакультура

Nájsť tento článok vo Web of Science

6

Перспективы использования неинвазивных методов получения генетического материала для молекулярных исследований биоразнообразия животных ; Perspektivy ispol'zovaniia neinvazivnykh metodov polucheniia geneticheskogo materiala dlia molekuliarnykh issledovanii bioraznoobraziia zhivotnykh

Autori: Волнистый Арсений Андреевич ГНПО «НПЦ НАН Беларуси по биоресурсам» Arsenii A. Volnistyi a ďalší

Zdroj: "The relevant problems of biological diversity"; 107-111 ; Актуальные проблемы биоразнообразия; 107-111

Predmety: молекулярная генетика, неинвазивные методы, древняя ДНК, генетические коллекции

Popis súboru: text/html

Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907830-16-5; https://phsreda.com/e-articles/10586/Action10586-110717.pdf; Amaral A. Detection of hybridization and species identification in domesticated and wild quails using genetic markers / A. Amaral, A. Silva, A. Grosso [et al.] // Folia Zoologica. – 2007. – Vol. 56.; Genetic diversity of the free-living population of Przewalski’s horses in the Chernobyl Exclusion Zone / E.E. Kheidorova, K.V. Homel, M.E. Nikiforov [et al.] // Theriol. Ukr. – 2021. – Vol. 2020. №20. – P. 58–66.; Homel K. Genetic structure and diversity of the capercaillie (Tetrao urogallus) population in Belarus in the context of de-lineation of two subspecies: major and pleskei / K. Homel, T. Pavlushchick, M. Nikiforov [et al.] // GEO&BIO. – 2022. – Vol. 2022. №22. – P. 113–128.; Homel K.V. Genetic Diversity and Place in the General Phylogeographic Structure of Capercaillie, Tetrao Urogallus (Galliformes, Phasianidae), from Belarus / K.V. Homel, T.E. Pavlushchick, M.E. Nikiforov [et al.] // Vestnik Zoologii. – 2019. – Vol. 53. №5. – P. 385–398. DOI 10.2478/vzoo-2019-0035. EDN ATVEYO; McNevin D. Preservation of and DNA Extraction from Muscle Tissue / D. McNevin // Forensic DNA Typing Protocols: Methods in Molecular Biology / ed. W. Goodwin. – New York: Springer New York, 2016. – Vol. 1420. – P. 43–53.; Valnisty A.A. Molecular genetic polymorphism of American mink populations (Neovison vison) in model fur farms and on the adjacent territories in Belarus / A.A. Valnisty, K.V. Homel, E.E. Kheidorova [et al.] // Dokl. Akad. nauk. – 2020. – Vol. 64. №6. – P. 685–693.; Valnisty A.A. Reintroduction shapes the genetic structure of the red deer (Cervus elaphus) population in Belarus / A.A. Valnisty, K.V. Homel, E.E. Kheidorova [et al.] // Theriol. Ukr. – 2022. – Vol. 2022. №23. – P. 31–46.; Angeloni F. Genomic toolboxes for conservation biologists / F. Angeloni, N. Wagemaker, P. Vergeer, J. Ouborg // Evolutionary Applications. – 2012. – Vol. 5. №2. – P. 130–143.; Banks S.C. Non-invasive genetic sampling is one of our most powerful and ethical tools for threatened species population monitoring: a reply to Lavery et al. / S.C. Banks, M.P. Piggott // Biodivers Conserv. – 2022. – Vol. 31. №2. – P. 723–728. DOI 10.1007/s10531-022-02377-x. EDN DWJGZO; Borrelli, L. Fecal Sample Collection Method for Wild Birds-Associated Microbiome Research: Perspectives for Wildlife Studies / L. Borrelli, A. Minichino, A. Pace [et al.] // Animals. – 2020. – Vol. 10. №8. – P. 1349.; Carroll, E.L. Genetic and genomic monitoring with minimally invasive sampling methods / E.L. Carroll, M.W. Bruford, J.A. DeWoody [et al.] // Evol Appl. – 2018. – Vol. 11. №7. – P. 1094–1119. DOI 10.1111/eva.12600. EDN YFSCJF; Chiou K.L. Methylation-based enrichment facilitates low-cost, noninvasive genomic scale sequencing of populations from feces / K.L. Chiou, C.M. Bergey // Sci Rep. – 2018. – Vol. 8. №1. – P. 1975.; De Barba, M. Comparing opportunistic and systematic sampling methods for non-invasive genetic monitoring of a small translocated brown bear population / M. De Barba, L.P. Waits, P. Genovesi [et al.] // Journal of Applied Ecology. – 2010. – Vol. 47. №1. – P. 172–181.; DEMatteo K.E. Noninvasive techniques provide novel insights for the elusive bush dog (Speothos venaticus): Noninvasive Techniques Speothos venaticus / K.E. DEMatteo, M.A. Rinas, C.F. Argüelles [et al.] // Wildl. Soc. Bull. – 2014. – Vol. 38. №4. – P. 862–873.; Field work ethics in biological research / M.J. Costello, K.H. Beard, R.T. Corlett [et al.] // Biological Conservation. – 2016. – Vol. 203. – P. 268–271.; Henry P. A Noninvasive Hair Sampling Technique to Obtain High Quality DNA from Elusive Small Mammals / P. Henry, A. Henry, M.A. Russello // JoVE. – 2011. №49. – P. 2791.; Hoffmann G.S. An improved high yield method to obtain microsatellite genotypes from red deer antlers up to 200 years old / G.S. Hoffmann, E.M. Griebeler // Mol Ecol Resour. – 2013. – Vol. 13. №3. – P. 440–446.; Hohenlohe P.A. Population genomics for wildlife conservation and management / P.A. Hohenlohe, W.C. Funk, O.P. Rajora // Molecular Ecology. – 2021. – Vol. 30, №1. – P. 62–82. DOI 10.1111/mec.15720. EDN XCMJMC; Holt W.V. Genome resource banking for wildlife conservation: promises and caveats / W.V. Holt, P. Comizzoli // Cryo Letters. – 2021. – Vol. 42. №6. – P. 309–320.; McMahon C.R. Publish or perish: why it’s important to publicise how, and if, research activities affect animals / C.R. McMahon, M.A. Hindell, R.G. Harcourt // Wildl. Res. – 2012. – Vol. 39. №5. – P. 375.; Russo D. Collection of voucher specimens for bat research: conservation, ethical implications, reduction, and alternatives / D. Russo, L. Ancillotto, A.C. Hughes [et al.] // Mammal Review. – 2017. – Vol. 47. №4. – P. 237–246. DOI 10.1111/mam.12095. EDN YGLEIF; Smith O. When can noninvasive samples provide sufficient information in conservation genetics studies? / O. Smith, J. Wang // Molecular Ecology Resources. – 2014. – Vol. 14. №5. – P. 1011–1023. DOI 10.1111/1755-0998.12250. EDN UWNEIH; Valnisty A.A. Between the lines: mitochondrial lineages in the heavily managed red deer population of Belarus / A.A. Valnisty, K.V. Homel, E.E. Kheidorova [et al.] // Mamm Biol. – 2024. – Vol. 104. №2. – P. 205–214.; Waits L.P. Noninvasive genetic sampling tools for wildlife biologists: a review of applications and recommendations for accurate data collection / L.P. Waits, D. Paetkau // Journal of Wildlife Management. – 2005. – Vol. 69. №4. – P. 1419–1433.; Wildt D.E. Genome resource banking for wildlife research, management, and conservation / D.E. Wildt // ILAR J. – 2000. – Vol. 41. №4. – P. 228–234.; Zemanova M.A. Noninvasive Genetic Assessment Is an Effective Wildlife Research Tool When Compared with Other Approaches / M.A. Zemanova // Genes (Basel). – 2021. – Vol. 12. №11. – P. 1672.; Волнистый А.А. Система единиц управления популяциями диких животных и генетические подходы для их выделения на примере благородного оленя в Беларуси / А.А. Волнистый, К.В. Гомель, П.А. Велигуров [и др.] // Природные ресурсы.; https://phsreda.com/article/110717/discussion_platform

Dostupnosť: https://phsreda.com/article/110717/discussion_platform
https://phsreda.com/files/Books/10586/Cover-10586.jpg?req=110717
https://doi.org/10.31483/r-110717

View record from BASE

Nájsť tento článok vo Web of Science

7

Molecular genetic characteristics of colorectal cancer ; Молекулярно-генетическая характеристика колоректального рака

Autori: B. D. Seferov O. Yu. Grickevich A. E. Lazarev a ďalší

Prispievatelia: B. D. Seferov O. Yu. Grickevich A. E. Lazarev a ďalší

Zdroj: Malignant tumours; Том 13, № 4 (2023); 78-83 ; Злокачественные опухоли; Том 13, № 4 (2023); 78-83 ; 2587-6813 ; 2224-5057

Predmety: мутации, molecular genetics, mutations, молекулярная генетика

Popis súboru: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1143/799; https://www.malignanttumors.org/jour/article/view/1143/905; Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71 (3) : 209–249. doi:10.3322/caac.21660.; Кит О.И., Дженкова Е.А., Мирзоян Э.А., Геворкян Ю.А., Сагакянц А.Б., Тимошкина Н.Н., идр. Молекулярногенетическая классификация подтипов колоректального рака : современное состояние проблемы. Южно-Российский онкологический журнал / SouthRussianJournalofCancer. 2021; 2 (2) : 50–56.; Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61 (5) : 759–767. doi:10.1016/0092-8674(90)90186-i.; Valenta T., Hausmann G., Basler K. The many faces and functions of b-catenin. EMBO J. 2012; 31 : 2714–2736.; Morin PJ. beta-catenin signaling and cancer. Bioessays. 1999; 21 (12) : 1021–1030.; Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, Garrett E, et al. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res. 2003; 63 (12) : 3145–3153.; Shivanna S., Harrold I., Shashar M., Meyer R., Kiang C., Francis J., et al. The c-Cbl ubiquitin ligase regulates nuclear β-catenin and angiogenesis by its tyrosine phosphorylation mediated through the Wnt signaling pathway. J Biol Chem. 2015. Doi:10.1074/jbc. M114.616623.; Muller MF, Ibrahim AEK, Arends MJ. Molecular pathological classifi cation of colorectal cancer. VirchowsArch. 2016; 469 (2) : 125–134.; Bosman F, Yan P. Molecular pathology of colorectal cancer. Pol J Pathol. 2014; 65 (4) : 257–266.; Pino MS, Chung DC. The chromosomal instability pathway in colon cancer. Gastroenterology. 2010; 138 (6) : 2059–72.; Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, et al. Tumour amplified kinase STK15 / BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998; 20 : 189–93.; Du R, Huang C, Liu K, Li X, Dong Z. Targeting AURKA in Cancer : molecular mechanisms and opportunities for Cancer therapy. Mol Cancer. 2021; 20 (1) : 15. doi:10.1186/s12943-020-01305-3.; Jacobsen A, Bosch LJW, Martens-de Kemp SR, Carvalho B, Sillars-Hardebol AH, Dobson RJ, et al. Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer. SciRep. 2018; 14; 8 (1) : 7522.; Santini D, Loupakis F, Vincenzi B, Floriani I, Stasi I, Canestrari, E, et al. High concordance of KRAS status between primary colorectal tumors and related metastatic sites : implications for clinical practice. Oncologist. 2008; 13 (12) : 1270–1275.; ТороповскийА. Н., ПавловаО. Н., ВикторовД. А., Никитин А.Г. Молекулярно-генетические механизмы сигнального каскада RAS-RAF-MEK-ERK, связанные с развитием опухолевого процесса и назначением таргетных препаратов при колоректальном раке. Вестник медицинского института «РЕАВИЗ». Реабилитация, Врач и Здоровье. 2021; (4) : 25–35.; Wan PT, Garnett MJ, Roe SM, Lee S, Niculescu-Duvaz D, Good VM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004; 116 (6) : 855–867. doi:10.1016/s0092-8674(04)00215-6.; Samuels Y, Velculescu VE. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle. 2004; 3 (10) : 1221–4.; Телышева Е.Н., Новикова Е.И., Снигирева Г.П. Молекулярно-генетические маркеры при колоректальном раке. Вестник Российского научного центра рентгенорадиологии Минздрава России. 2019; 19 : 3 : 96–121.; Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993; 260 (5109) : 816–9.; Vilar E, Gruber SB. Microsatellite instability in colorectal cancer-the stable evidence. Nat Rev ClinOncol. 2010; 7 (3) : 153–62.; Федянин М.Ю., Трякин А.А., Тюляндин С.А. Роль микросателлитной нестабильности при раке толстой кишки. Тазоваяхирургия и онкология. 2012; (3) : 19–25. https://doi.org/10.17650/2220-3478-2012-0-3-321-338.; Алексей А. Трякин, Гульноз Г. Хакимова, Татьяна Н. Заботина, Анна А. Борунова, & Ольга А. Малихова. Современные иммунологические биомаркеры рака толстой кишки. Злокачественные опухоли. 2018; 8 : 4 : 50–58. doi:10.18027/2224-5057-2018-8-4-50-58.; De’ Angelis GL, Bottarelli L, Azzoni C, De’ Angelis N, Leandro G, Di Mario F, et al. Microsatellite instability in colorectal cancer. Acta Biomed. 2018; 89 (9-S) : 97–101.; Suvà ML, Riggi N, Bernstein BE. Epigenetic Reprogramming in Cancer. Science (2013) 339 : 1567–70.; Куликов Е.П., Судаков А.И., Никифоров А.А., Мерцалов С.А., Григоренко В.А. Значение полиморфизма генов в развитии колоректального рака. Российский медико-биологический вестник им. академика И.П. Павлова. 2020 : 28 : 2 : 127–134.; https://www.malignanttumors.org/jour/article/view/1143

Dostupnosť: https://www.malignanttumors.org/jour/article/view/1143
https://doi.org/10.18027/2224-5057-2023-13-4-78-83

View record from BASE

Nájsť tento článok vo Web of Science

8

Молекурно-фитопатологический подход к видовой идентификации грибов из рода Heterobsidion spp., инфицирующих ель европейскую в Беларуси

Autori: Нестюк, Антонина Михайловна

Predmety: молекулярная генетика, лесная фитопатология, ель европейская, корневая губка, корневая гниль, молекулярно-генетический анализ, болезни деревьев

Popis súboru: application/pdf

Relation: https://elib.belstu.by/handle/123456789/72072; 630*416.3(476)

Dostupnosť: https://elib.belstu.by/handle/123456789/72072

View record from BASE

Nájsť tento článok vo Web of Science

9

Comparative study of genomic, immunological and functional features of squamous cell carcinomas in five anatomical locations ; STUDIUL COMPARATIV AL PARTICULARITĂȚILOR GENOMICE, IMUNOLOGICE ȘI FUNCȚIONALE ALE CARCINOAMELOR CU CELULE SCUAMOASE ÎN CINCI LOCALIZĂRI ANATOMICE ; Сравнителъное исследование геномных, иммунологических и функционалъных особенностей плоскоклеточного карцинома в пяти анатомических локализациях.

Autori: STRATAN, Valentina

Zdroj: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 71 No. 3 (2021): Medical Sciences; 178-186 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 71 Nr. 3 (2021): Ştiinţe medicale; 178-186 ; Вестник Академии Наук Молдовы. Медицина; Том 71 № 3 (2021): Медицина; 178-186 ; 1857-0011 ; 10.52692/1857-0011.2021.3-71

Popis súboru: application/pdf

Relation: https://bulmed.md/bulmed/article/view/3373/3377; https://bulmed.md/bulmed/article/view/3373

Dostupnosť: https://bulmed.md/bulmed/article/view/3373
https://doi.org/10.52692/1857-0011.2021.3-71.05

View record from BASE

Nájsť tento článok vo Web of Science

10

Determination of deletion carrier of exon 7 of the SMN1 gene by the QPCR method

Autori: Coliban, I. Uşurelu, N.M. Revenco, N.E. a ďalší

Zdroj: Buletin de Perinatologie 90 (1) 42-45

Predmety: genetică moleculară, diagnostic, deleție, purtător, screening, SMA, молекулярная генетика, диагностика, ПЦР носительство, скрининг, СМА

Popis súboru: application/pdf

Relation: https://ibn.idsi.md/vizualizare_articol/137641; urn:issn:18105289

Dostupnosť: https://ibn.idsi.md/vizualizare_articol/137641

View record from BASE

Nájsť tento článok vo Web of Science

11

Atypical teratoid-rhabdoid tumors: molecular genetics feutures, perspectives of treatment. Review of literature ; Атипические тератоидно-рабдоидные опухоли: молекулярно-генетические особенности, перспективы лечения. Обзор литературы

Autori: A. Yu. Smirnova A. Yu. Goncharov Yu. V. Dinikina a ďalší

Zdroj: Russian Journal of Pediatric Hematology and Oncology; Том 7, № 1 (2020); 41-50 ; Российский журнал детской гематологии и онкологии (РЖДГиО); Том 7, № 1 (2020); 41-50 ; 2413-5496 ; 2311-1267 ; 10.21682/2311-1267-2020-7-1

Predmety: перспективы лечения, molecular genetic, genetic groups, perspectives of treatment, молекулярная генетика, генетические группы

Popis súboru: application/pdf

Relation: https://journal.nodgo.org/jour/article/view/573/534; Fonseca A., Al-Karmi S., Vasiljevic A., Dodghsun A., Sin Chan P., Lafay Cousin L., Hansford J., Huang A. Rare embrional brain tumors. In: Brain tumors in children. Springer, 2018. Pp. 302–309.; Richardson E.A., Ho B., Huang A. Atypical teratoid rhabdoid tumor: from tumors to therapies. J Korean Neurosurg Soc 2018;61(3):302–11. doi:10.3340/jkns.2018.0061.; Roberts C.W.M. SWI/SNF (BAF) complex mutations in cancer. In: Proceedings of the AACR Special Conference on Advances in Pediatric Cancer Research: From Mechanisms and Models to Treatment and Survivorship; 2015 Nov 9–12; Fort Lauderdale, FL. Philadelphia (PA): AACR. Cancer Res 2015;76(5 Suppl):abstr. IA12.; Gonzales M. The 2000 World Health Organization classification of tumors of the nervous system. J Clin Neurosci 2001;8:1–3. doi:10.1054/jocn.2000.0829.; Louis D.N., Perry A., Reifenberger G., von Deimling A., Figarella-Branger D., Cavenee W.K., Ohgaki H., Wiestler O.D., Kleihues P., Ellison D.W. The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 2016;131:803–20. doi:10.1007/s00401-016-1545-1.; Torchia J., Golbourn B., Feng S., Ho K.C., Sin-Chan P., Vasiljevic A., Norman J.D., Guilhamon P., Garzia L., Agamez N.R., Lu M., Chan T.S., Picard D., de Antonellis P., Khuong-Quang D.A., Planello A.C., Zeller C., Barsyte-Lovejoy D., Lafay-Cousin L., Letourneau L., Bourgey M., Yu M., Gendoo D.M.A., Dzamba M., Barszczyk M., Medina T., Riemenschneider A.N., Morrissy A.S., Ra Y.S., Ramaswamy V., Remke M., Dunham C.P., Yip S., Ng H.K., Lu J.Q., Mehta V., Albrecht S., Pimentel J., Chan J.A., Somers G.R., Faria C.C., Roque L., Fouladi M., Hoffman L.M., Moore A.S., Wang Y., Choi S.A., Hansford J.R., Catchpoole D., Birks D.K., Foreman N.K., Strother D., Klekner A., Bognár L., Garami M., Hauser P., Hortobágyi T., Wilson B., Hukin J., Carret A.S., Van Meter T.E., Hwang E.I., Gajjar A., Chiou S.H., Nakamura H., Toledano H., Fried I., Fults D., Wataya T., Fryer C., Eisenstat D.D., Scheinemann K., Fleming A.J., Johnston D.L., Michaud J., Zelcer S., Hammond R., Afzal S., Ramsay D.A., Sirachainan N., Hongeng S., Larbcharoensub N., Grundy R.G., Lulla R.R., Fangusaro J.R., Druker H., Bartels U., Grant R., Malkin D., McGlade C.J., Nicolaides T., Tihan T., Phillips J., Majewski J., Montpetit A., Bourque G., Bader G.D., Reddy A.T., Gillespie G.Y., Warmuth-Metz M., Rutkowski S., Tabori U., Lupien M., Brudno M., Schüller U., Pietsch T., Judkins A.R., Hawkins C.E., Bouffet E., Kim S.K., Dirks P.B., Taylor M.D., Erdreich-Epstein A., Arrowsmith C.H., De Carvalho D.D., Rutka J.T., Jabado N., Huang A. Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 2016;30:891–908. doi:10.1016/j.ccell.2016.11.003.; Johann P.D., Erkek S., Zapatka M., Kerl K., Buchhalter I., Hovestadt V., Jones D.T.W., Sturm D., Hermann C., Segura W.M., Korshunov A., Rhyzova M., Gröbner S., Brabetz S., Chavez L., Bens S., Gröschel S., Kratochwil F., Wittmann A., Sieber L., Geörg C., Wolf S., Beck K., Oyen F., Capper D., van Sluis P., Volckmann R., Koster J., Versteeg R., von Deimling A., Milde T., Witt O., Kulozik A.E., Ebinger M., Shalaby T., Grotzer M., Sumerauer D., Zamecnik J., Mora J., Jabado N., Taylor M.D., Huang A., Aronica E., Bertoni A., Radlwimmer B., Pietsch T., Schüller U., Schneppenheim R., Northcott P.A., Korbel J.O., Siebert R., Frühwald M.C., Lichter P., Eils R., Gajjar A., Hasselblatt M., Pfister S.M., Kool M. Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 2016;29:379–93. doi:10.1016/j.ccell.2016.02.001.; Burger P.C., Yu I.T., Tihan T., Friedman H.S., Strother D.R., Kepner J.L., Duffner P.K., Kun L.E., Perlman E.J. Atypical teratoid/ rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol 1998;22:1083–92. doi: https://doi.org/10.1097/00000478-199809000-00007.; Hilden J.M., Meerbaum S., Burger P., Finlay J., Janss A., Scheithauer B.W., Walter A.W., Rorke L.B., Biegel J.A. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. J Clin Oncol 2004;22:2877–84. doi:10.1200/JCO.2004.07.073.; Tekautz T.M., Fuller C.E., Blaney S., Fouladi M., Broniscer A., Merchant T.E., Krasin M., Dalton J., Hale G., Kun L.E., Wallace D., Gilbertson R.J., Gajjar A. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 2005;23:1491–9. doi:10.1200/JCO.2005.05.187.; Fruhwald M.C., Biegel J.A., Bourdeaut F., Roberts C.W., Chi S.N. Atypical teratoid/rhabdoid tumors – current concepts, advances in biology, and potential future therapies. Neuro Oncol 2016;18:764–78. doi:10.1093/neuonc/nov264.; Dufour C., Beaugrand A., Le Deley M.C., Bourdeaut F., André N., Leblond P., Bertozzi A.I., Frappaz D., Rialland X., Fouyssac F., Edan C., Grill J., Quidot M., Varlet P. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 2012;118:3812–21. doi:10.1002/cncr.26684.; von Hoff K., Hinkes B., Dannenmann-Stern E., von Bueren A.O., Warmuth-Metz M., Soerensen N., Emser A., Zwiener I., Schlegel P.G., Kuehl J., Kortmann R.D., Pietsch T., Rutkowski S. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 2011;57:978–85. doi:10.1002/pbc.23236.; Pai Panandiker A.S., Merchant T.E., Beltran C., Wu S., Sharma S., Boop F.A., Jenkins J.J., Helton K.J., Wright K.D., Broniscer A., Kun L.E., Gajjar A. Sequencing of local therapy affects the pattern of treatment failure and survival in children with atypical teratoid rhabdoid tumors of the central nervous system. Int J Radiat Oncol Biol Phys 2012;82:1756–63. doi: https://doi.org/10.1016/j.ijrobp.2011.02.059.; Park E.S., Sung K.W., Baek H.J., Park K.D., Park H.J., Won S.C., Lim D.H., Kim H.S. Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/ rhabdoid tumor of the central nervous system. J Korean Med Sci 2012;27:135–40. doi: http://dx.doi.org/10.3346/jkms.2012.27.2.135.; Athale U.H., Duckworth J., Odame I., Barr R. Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies. J Pediatr Hematol Oncol 2009;31:651–63. doi:10.1097/MPH.0b013e3181b258a9.; Chi S.N., Zimmerman M.A., Yao X., Cohen K.J., Burger P., Biegel J.A., Rorke-Adams L.B., Fisher M.J., Janss A., Mazewski C., Goldman S., Manley P.E., Bowers D.C., Bendel A., Rubin J., Turner C.D., Marcus K.J, Goumnerova L., Ullrich N.J., Kieran M.W. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 2009;27:385–9. doi:10.1200/JCO.2008.18.7724.; Lafay-Cousin L., Hawkins C., Carret A.S., Johnston D., Zelcer S., Wilson B., Jabado N., Scheinemann K., Eisenstat D., Fryer C., Fleming A., Mpofu C., Larouche V., Strother D., Bouffet E., Huang A. Central nervous system atypical teratoid rhabdoid tumours: the Canadian paediatric brain tumour consortium experience. Eur J Cancer 2012;48:353–9. doi:10.1016/j.ejca.2011.09.005.; Buscariollo D.L., Park H.S., Roberts K.B., Yu J.B. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 2012;118:4212–9. doi:10.1002/cncr.27373.; Rorke L.B., Packer R.J., Biegel J.A. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56–65. doi: https://doi.org/10.3171/jns.1996.85.1.0056.; Schrey D., Carceller Lechon F., Malietzis G., Moreno L., Dufour C., Chi S., Lafay-Cousin L., von Hoff K., Athanasiou T., Marshall L.V., Zacharoulis S. Multimodal therapy in children and adolescents with newly diagnosed atypical teratoid rhabdoid tumor: individual pooled data analysis and review of the literature. J Neurooncol 2016;126:81–90. doi:10.1007/s11060-015-1904-0.; Woehrer A., Slavc I., Waldhoer T., Heinzl H., Zielonke N., Czech T., Benesch M., Hainfellner J.A., Haberler C.; Austrian Brain Tumor Registry. Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996–2006. Cancer 2010;116:5725–32. doi:10.1002/cncr.25540.; Ginn K.F., Gajjar A. Atypical teratoid rhabdoid tumor: current therapy and future directions. Front Oncol 2012;2:114. doi:10.3389/fonc.2012.00114.; Slavc I., Chocholous M., Leiss U., Haberler C., Peyrl A., Azizi A.A., Dieckmann K., Woehrer A., Peters C., Widhalm G., Dorfer C., and Czech T. Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012. Cancer Med 2014;3(1):91–100. doi:10.1002/cam4.161.; Torchia J., Picard D., Lafay-Cousin L., Hawkins C.E., Kim S.K., Letourneau L., Ra Y.S., Ho K.C., Chan T.S., Sin-Chan P., Dunham C.P., Yip S., Ng H.K., Lu J.Q., Albrecht S., Pimentel J., Chan J.A., Somers G.R., Zielenska M., Faria C.C., Roque L., Baskin B., Birks D., Foreman N., Strother D., Klekner A., Garami M., Hauser P., Hortobágyi T., Bognár L., Wilson B., Hukin J., Carret A.S., Van Meter T.E., Nakamura H., Toledano H., Fried I., Fults D., Wataya T., Fryer C., Eisenstat D.D., Scheineman K., Johnston D., Michaud J., Zelcer S., Hammond R., Ramsay D.A., Fleming A.J., Lulla R.R., Fangusaro J.R., Sirachainan N., Larbcharoensub N., Hongeng S., Barakzai M.A., Montpetit A., Stephens D., Grundy R.G., Schüller U., Nicolaides T., Tihan T., Phillips J., Taylor M.D., Rutka J.T., Dirks P., Bader G.D., Warmuth-Metz M., Rutkowski S., Pietsch T., Judkins A.R., Jabado N., Bouffet E., Huang A. Molecular subgroups of atypical teratoid rhabdoid tumors in children: an integrated genomic and clinicopathological analysis. Lancet Oncol 2015;16:569–82. doi:10.1016/S1470-2045(15)70114-2.; Birks D.K., Donson A.M., Patel P.R., Dunham C., Muscat A., Algar E.M., Ashley D.M., Kleinschmidt-Demasters B.K., Vibhakar R., Handler M.H., Foreman N.K. High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol 2011;13:1296–307. doi:10.1093/neuonc/nor140.; Biegel J.A., Zhou J.Y., Rorke L.B., Stenstrom C., Wainwright L.M., Fogelgren B. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999;59:74–9. PMID: 9892189.; Bourdeaut F., Lequin D., Brugieres L., Reynaud S., Dufour C., Doz F., André N., Stephan J.L., Pérel Y., Oberlin O., Orbach D., Bergeron C., Rialland X., Fréneaux P., Ranchere D., Figarella-Branger D., Audry G., Puget S., Evans D.G., Pinas J.C., Capra V., Mosseri V., Coupier I., Gauthier-Villars M., Pierron G., Delattre O. Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 2011;17:31–8. doi:10.1158/1078-0432.CCR-10-1795.; Eaton K.W., Tooke L.S., Wainwright L.M., Judkins A.R., Biegel J.A. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011;56:7–15. doi:10.1002/pbc.22831.; Hasselblatt M., Gesk S., Oyen F., Rossi S., Viscardi E., Giangaspero F., Giannini C., Judkins A.R., Frühwald M.C., Obser T., Schneppenheim R., Siebert R., Paulus W. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 2011;35:933–5. doi:10.1097/PAS.0b013e3182196a39.; Haberler C., Laggner U., Slavc I., Czech T., Ambros I.M., Ambros P.F., Budka H., Hainfellner J.A. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 2006;30:1462–8. doi:10.1097/01.pas.0000213329.71745.ef.; Hasselblatt M., Isken S., Linge A., Eikmeier K., Jeibmann A., Oyen F., Nagel I., Richter J., Bartelheim K., Kordes U., Schneppenheim R., Frühwald M., Siebert R., Paulus W. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Genes Chromosomes Cancer 2013;52:185–90. doi:10.1002/gcc.22018.; Han Z.Y., Richer W., Fréneaux P., Chauvin C., Lucchesi C., Guillemot D., Grison C., Lequin D., Pierron G., Masliah-Planchon J., Nicolas A., Ranchère-Vince D., Varlet P., Puget S., Janoueix-Lerosey I., Ayrault O., Surdez D., Delattre O., Bourdeaut F. The occurrence of intracranial rhabdoid tumors in mice depends on temporal control of Smarcb1 inactivation. Nat Commun 2016;7:10421. doi:10.1038/ncomms10421.; Wilson B.G., Wang X., Shen X., McKenna E.S., Lemieux M.E., Cho Y.-J., Koellhoffer E.C., Pomeroy S.L., Orkin S.H., Roberts C.W.M. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 2010;18:316–28. doi:10.1016/j.ccr.2010.09.006.; Ким А.В., Самочерных К.А., Солтан П.С., Дон О.А., Захарчук Е.В., Хачатрян В.А. Особенности опухолей головного мозга и их хи- рургического лечения у детей первых двух лет жизни. Вестник хирургии им. И.И. Грекова 2011;170(4):68–72.; Хачатрян В.А., Улитин А.Ю., Кумирова Э.В., Желудкова О.Г., Румянцев А.Г., Ким А.В., Самочерных К.А., Тадевосян А.Р., Дон О.А., Солтан П.С., Пальцев А.А. Медуллобластома у детей (обзор литературы). Часть 2. Комплексное лечение. Нейрохирур- гия и неврология детского возраста 2014;2(40):68–80.; Jin B., Feng X.Y. MRI features of atypical teratoid/rhabdoid tumors in children. Pediatr Radiol 2013;43:1001–8. doi:10.1007/s00247-013-2646-9.; Tomita T., Frassanito P. Tumors of the superior medullary velum in infancy and childhood: report of 6 cases. J Neurosurg Pediatr 2013;11:52–9. doi: https://doi.org/10.3171/2012.9.PEDS12236.; Bartelheim K., Nemes K., Seeringer A., Kerl K., Buechner J., Boos J., Graf N., Dürken M., Gerss J., Hasselblatt M., Kortmann R.D., von Luettichau I.T., Nagel I., Nygaard R., Oyen F., Quiroga E., Schlegel P.G., Schmid I., Schneppenheim R., Siebert R., Solano-Paez P., Timmermann B., Warmuth-Metz M., Frühwald M.C. Improved 6-year overall survival in AT/RT – results of the registry study Rhabdoid 2007. Cancer Med 2016;5(8):1765–75. doi:10.1002/cam4.741.; Cohen B.H., Geyer J.R., Miller D.C., Curran J.G., Zhou T., Holmes E., Ingles S.A., Dunkel I.J., Hilden J., Packer R.J., Pollack I.F., Gajjar A., Finlay J.L.; Children’s Oncology Group. Pilot study of intensive chemotherapy with peripheral hematopoietic cell support for children less than 3 years of age with malignant brain tumors, the CCG-99703 phase I/II study. A report from the children’s oncology group. Pediatr Neurol 2015;53:31–46. doi:10.1016/j.pediatrneurol.2015.03.019.; Ho D.M., Hsu C.Y., Wong T.T., Ting L.T., Chiang H. Atypical teratoid/ rhabdoid tumor of the central nervous system: a comparative study with primitive neuroectodermal tumor/medulloblastoma. Acta Neuropathol 2000;99:482–8. doi:10.1007/s004010051149.; Tang Y., Gholamin S., Schubert S., Willardson M.I., Lee A., Bandopadhayay P., Bergthold G., Masoud S., Nguyen B., Vue N., Balansay B., Yu F., Oh S., Woo P., Chen S., Ponnuswami A., Monje M., Atwood S.X., Whitson R.J., Mitra S., Cheshier S.H., Qi J., Beroukhim R., Tang J.Y., Wechsler-Reya R., Oro A.E., Link B.A., Bradner J.E., Cho Y.J. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nat Med 2014;20:732–40. doi:10.1038/nm.3613.; Gardner S.L., Asgharzadeh S., Green A., Horn B., McCowage G., Finlay J. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 2008;51:235–40. doi:10.1002/pbc.21578.; Zaky W., Dhall G., Ji L., Haley K., Allen J., Atlas M., Bertolone S., Cornelius A., Gardner S., Patel R., Pradhan K., Shen V., Thompson S., Torkildson J., Sposto R., Finlay J.L. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 2014;61:95–101. doi:10.1002/pbc.24648.; Гогорян С.Ф., Берснев В.П., Ким А.В., Самочерных К.А., Малхасян Ж.Г. Злокачественные опухоли головного мозга, сочетающиеся с гидроцефалией. Журнал «Вопросы нейрохирургии» им. Н.Н. Бурденко 2008;4:39−43.; Zimmerman M.A., Goumnerova L.C., Proctor M., Scott R.M., Marcus K., Pomeroy S.L., Turner C.D., Chi S.N., Chordas C., Kieran M.W. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. J Neurooncol 2005;72(1):77–84. doi:10.1007/s11060-004-3115-y.; Finkelstein-Shechter T., Gassas A., Mabbott D., Huang A., Bartels U., Tabori U., Janzen L., Hawkins C., Taylor M., Bouffet E. Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 2010;32:e182–6. doi:10.1097/MPH.0b013e3181dce1a2.; Диникина Ю.В., Белогурова М.Б. Атипические тератоидно-рабдоидные опухоли центральной нервной системы у детей: состояние проблемы на сегодняшний день. Обзор литературы. Российский журнал детской гематологии и онкологии 2018;4(5):60–73. doi:10.17650/2311-1267-2018-5-4-60-73.; Nicolaides T., Tihan T., Horn B., Biegel J., Prados M., Banerjee A. High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 2010;98:117–23. doi:10.1007/s11060-009-0071-6.; Fangusaro J.R., Jubran R.F., Allen J., Gardner S., Dunkel I.J., Rosenblum M., Atlas M.P., Gonzalez-Gomez I., Miller D., Finlay J.L. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue. Pediatr Blood Cancer 2008;50:715–7. doi:10.1002/pbc.21032.; Kadoch C., Hargreaves D.C., Hodges C., Elias L., Ho L., Ranish J., Crabtree G.R. Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy. Nat Genet 2013;45:592–601. doi:10.1038/ng.2628.; Tsikitis M., Zhang Z., Edelman W., Zagzag D., Kalpana G.V. Genetic ablation of Cyclin D1 abrogates genesis of rhabdoid tumors resulting from Ini1 loss. Proc Natl Acad Sci USA 2005;102:12129–34. doi:10.1073/pnas.0505300102.; Lee S., Cimica V., Ramachandra N., Zagzag D., Kalpana G.V. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Cancer Res 2011;71:3225–35. doi:10.1158/0008-5472.CAN-10-2167.; Ogino S., Kubo S., Abdul-Karim F.W., Cohen M.L. Comparative immunohistochemical study of insulin- like growth factor II and insulin-like growth factor receptor type 1 in pediatric brain tumors. Pediatr Dev Pathol 2001;4:23–31. doi:10.1007/s100240010112.; Knipstein J.A., Birks D.K., Donson A.M., Alimova I., Foreman N.K., Vibhakar R. Histone deacetylase inhibition decreases proliferation and potentiates the effect of ionizing radiation in atypical teratoid/ rhabdoid tumor cells. Neuro Oncol 2012;14(2):175–83. doi:10.1093/neuonc/nor208.; Maris J.M., Morton C.L., Gorlick R., Kolb E.A., Lock R., Carol H., Keir S.T., Reynolds C.P., Kang M.H., Wu J., Smith M.A., Houghton P.J. Initial testing of the aurora kinase a inhibitor MLN8237 by the Pediatric Preclinical Testing Program (PPTP). Pediatr Blood Cancer 2010;55:26–34. doi:10.1002/pbc.22430.; Koos B., Jeibmann A., Lünenbürger H., Mertsch S., Nupponen N.N., Roselli A., Leuschner I., Paulus W., Frühwald M.C., Hasselblatt M. The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumors. Cancer 2010;116:5075–81. doi:10.1002/cncr.25420.; Bikowska B., Grajkowska W., Jozwiak J. Atypical teratoid/rhabdoid tumor: short clinical description and insight into possible mechanism of the disease. Eur J Neurol 2011;18:813–8. doi:10.1111/j.1468-1331.2010.03277.x.; Jayanthan A., Bernoux D., Bose P., Riabowol K., Narendran A. Multi-tyrosine kinase inhibitors in preclinical studies for pediatric CNS AT/ RT: evidence for synergy with topoisomerase-I inhibition. Cancer Cell Int 2011;11:44. doi: https://doi.org/10.1186/1475-2867-11-44.; https://journal.nodgo.org/jour/article/view/573

Dostupnosť: https://journal.nodgo.org/jour/article/view/573
https://doi.org/10.21682/2311-1267-2020-7-1-41-50

View record from BASE

Nájsť tento článok vo Web of Science

12